These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 34291283)

  • 1. Lessons from the field: delivering trachoma mass drug administration safely in a COVID-19 context.
    Amanyi-Enegela JA; Burn N; Dirisu O; Ebenso B; Sankar G; Ishaya R; Ogoshi C; Kumbur J; Ekweremadu B; Qureshi BM
    Trans R Soc Trop Med Hyg; 2021 Oct; 115(10):1102-1105. PubMed ID: 34291283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling trachoma post-2020: opportunities for mitigating the impact of COVID-19 and accelerating progress towards elimination.
    Borlase A; Blumberg S; Callahan EK; Deiner MS; Nash SD; Porco TC; Solomon AW; Lietman TM; Prada JM; Hollingsworth TD
    Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):213-221. PubMed ID: 33596317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of the COVID-19 pandemic in eliminating trachoma as a public health problem.
    Blumberg S; Borlase A; Prada JM; Solomon AW; Emerson P; Hooper PJ; Deiner MS; Amoah B; Hollingsworth TD; Porco TC; Lietman TM
    Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):222-228. PubMed ID: 33449114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of mass drug administration for neglected tropical diseases in Guinea during the COVID-19 pandemic.
    Sakho F; Badila CF; Dembele B; Diaby A; Camara AK; Lamah L; Reid SD; Weng A; Fuller BB; Sanchez KA; Kabore A; Zhang Y; Weaver A
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009807. PubMed ID: 34570807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restarting Neglected Tropical Diseases Programs in West Africa during the COVID-19 Pandemic: Lessons Learned and Best Practices.
    Kabore A; Palmer SL; Mensah E; Ettiegne-Traore V; Monteil R; Sintondji F; Tine J; Tesfaye D; Ogoussan K; Stukel D; Fuller BB; Sanchez K; Pou B; Dembele B; Weaver A; Reid S; Milord MD; Kassankogno Y; Seim A; Shott J
    Am J Trop Med Hyg; 2021 Oct; 105(6):1476-1482. PubMed ID: 34670193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of modelling to modify trachoma elimination strategies affected by the COVID-19 pandemic.
    Emerson PM; Hooper PJ; Gebre T
    Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):211-212. PubMed ID: 33421962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coverage, social mobilization and challenges of mass Zithromax administration campaign in South and South East zones of Tigray, Northern Ethiopia: A cross sectional study.
    Mulugeta A; Gebregergs GB; Asfaw S; Yemane D; Mitiku M; Meresa B; Gigar G; Kidane A
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006288. PubMed ID: 29481558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa.
    Last AR; Burr SE; Harding-Esch E; Cassama E; Nabicassa M; Roberts CH; Mabey DCW; Holland MJ; Bailey RL
    Parasit Vectors; 2017 Dec; 10(1):624. PubMed ID: 29282126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safely resuming neglected tropical disease control activities during COVID-19: Perspectives from Nigeria and Guinea.
    McKay S; Shu'aibu J; Cissé A; Knight A; Abdullahi F; Ibrahim A; Madaki S; Genovezos C; McCoy K; Downs P; Kabore A; Adamu H; Gobir IB; Chaitkin M; Standley CJ
    PLoS Negl Trop Dis; 2021 Dec; 15(12):e0009904. PubMed ID: 34928945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coverage assessment survey following trachoma mass drug administration (MDA) in six districts of Oromia, Western Ethiopia, 2017.
    Bekuma TT; Mosisa Kebebew G; Desalegn Waktole Z; Markos Cafo J; Wirtu D; Gaddisa S
    PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007924. PubMed ID: 31841516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal.
    Harding-Esch EM; Holland MJ; Schémann JF; Sillah A; Sarr B; Christerson L; Pickering H; Molina-Gonzalez S; Sarr I; Andreasen AA; Jeffries D; Grundy C; Mabey DCW; Herrmann B; Bailey RL
    Parasit Vectors; 2019 Oct; 12(1):497. PubMed ID: 31640755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding hard-to-reach communities: local perspectives and experiences of trachoma control among the pastoralist Maasai in northern Tanzania.
    Mtuy TB; Bardosh K; Ngondi J; Mwingira U; Seeley J; Burton M; Lees S
    J Biosoc Sci; 2021 Nov; 53(6):819-838. PubMed ID: 32981544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia.
    Astale T; Sata E; Zerihun M; Nute AW; Stewart AEP; Gessese D; Ayenew G; Melak B; Chanyalew M; Tadesse Z; Callahan EK; Nash SD
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006270. PubMed ID: 29451881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neglected tropical diseases activities in Africa in the COVID-19 era: the need for a "hybrid" approach in COVID-endemic times.
    Molyneux D; Bush S; Bannerman R; Downs P; Shu'aibu J; Boko-Collins P; Radvan I; Wohlgemuth L; Boyton C
    Infect Dis Poverty; 2021 Jan; 10(1):1. PubMed ID: 33397494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular Chlamydia trachomatis infection: elimination with mass drug administration.
    Wolle MA; West SK
    Expert Rev Anti Infect Ther; 2019 Mar; 17(3):189-200. PubMed ID: 30698042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of
    Gwyn SE; Xiang L; Kandel RP; Dean D; Gambhir M; Martin DL
    Am J Trop Med Hyg; 2018 Jan; 98(1):216-220. PubMed ID: 29141720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population coverage and factors associated with participation following a mass drug administration of azithromycin for trachoma elimination in Amhara, Ethiopia.
    Ebert CD; Astale T; Sata E; Zerihun M; Nute AW; Stewart AEP; Gessese D; Ayenew G; Ayele Z; Melak B; Chanyalew M; Gashaw B; Tadesse Z; Callahan EK; Jenness SM; Nash SD
    Trop Med Int Health; 2019 Apr; 24(4):493-501. PubMed ID: 30674087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units.
    Burr SE; Hart J; Samikwa L; Chaima D; Cooley G; Martin D; Masika M; Solomon AW; Bailey RL; Kalua K
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007749. PubMed ID: 31658258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-centered communication of community treatment assistants in Tanzania predicts coverage of future mass drug administration for trachoma.
    Jenson A; Roter DL; Mkocha H; Munoz B; West S
    Patient Educ Couns; 2018 Jun; 101(6):1075-1081. PubMed ID: 29329726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Infection with Chlamydia trachomatis from Migrants to Communities Undergoing Mass Drug Administration for Trachoma Control.
    West SK; Munoz BE; Mkocha H; Gaydos C; Quinn T
    Ophthalmic Epidemiol; 2015; 22(3):170-5. PubMed ID: 26158574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.